Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 5—May 2023
Research

SARS-CoV-2 Seroprevalence Compared with Confirmed COVID-19 Cases among Children, Colorado, USA, May–July 2021

Shannon C. O’BrienComments to Author , Lyndsey D. Cole, Bernadette A. Albanese, Allison Mahon, Vijaya Knight, Nathan Williams, Rachel Severson, Alexis Burakoff, Nisha B. Alden, and Samuel R. Dominguez
Author affiliations: Colorado Department of Public Health and Environment, Denver, Colorado, USA (S.C. O’Brien, N. Williams, R. Severson, A. Burakoff, N.B. Alden); Children’s Hospital Colorado, Aurora, Colorado, USA (L.D. Cole, A. Mahon, V. Knight, S.R. Dominguez); Tri-County Health Department, Greenwood Village, Colorado, USA (B.A. Albanese)

Main Article

Figure 1

Days between first positive diagnostic test result and sample collection for serology testing for SARS-CoV-2 IgG, Colorado, USA, May 12–July 13, 2021. N, nucleocapsid; S, spike.

Figure 1. Days between first positive diagnostic test result and sample collection for serology testing for SARS-CoV-2 IgG, Colorado, USA, May 12–July 13, 2021. N, nucleocapsid; S, spike.

Main Article

1Preliminary results from this study were presented at the Council of State and Territorial Epidemiologists Conference; Louisville, Kentucky, USA; June 19–23, 2022.

Page created: March 27, 2023
Page updated: April 18, 2023
Page reviewed: April 18, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external